Open Maxillary Sinus Augmentation Using Different Types of Bone Particles

Maxillary Sinus Augmentation Clinical Trial

Official title:

Two Stage Sinus Lifting Using Nano Hydroxyapatite Particles [Nanostreams] Versus Deprotenized Bovine Bone [Tutogen] : Randomized Clinical Trial.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03184857
• Other study ID #: Cebc.cairouniversity - 1025
• Status: Completed
• Phase: N/A
• Start date: July 1, 2017
• Est. completion date: September 30, 2019

Study information

• Verified date: March 2024
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Two stage sinus lifting using Nano hydroxyapatite particles [Nanostreams] versus Deprotenized bovine bone [Tutogen] : Randomized clinical trial.

comparing between Height of new bone formation, Bone area percent( Histomorphometric)

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: September 30, 2019
• Est. primary completion date: September 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

-

Exclusion Criteria:

• sinus pathology

• heavy smokers

• patients with systemic disease uncontrolled

Related Conditions & MeSH terms

• Maxillary Sinus Augmentation

Intervention

Procedure:
• open maxillary sinus lifting
biopsy of the region 6 months later

Locations

Country	Name	City	State
Egypt	Mahmoud Ahmed Nour Eldeen	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	histomorphometric analysis	histomorphometric analysis to measure new bone percent formation and residual bone graft percent	6 months
Secondary	new height of bone gained	CBCT 6 months postoperative to measure the new height of bone	6 months